publication date: Mar. 6, 2020

In Brief

Roswell Park signs on to participate in ASCO’s CancerLinQ

Roswell Park Comprehensive Cancer Center has signed on to use the CancerLinQ platform.

“We hope to use it to enhance our quality oversight, benchmark care, use with other data to better understand care delivery and quality, and support local and national research efforts,” Stephen Edge, vice president of Healthcare Outcomes and Policy at Roswell Park, said in a statement.

CancerLinQ has more than 100 subscribers. In addition to Roswell Park, practices including Baptist Healthcare System, and Crystal Run Healthcare, have signed agreements to join the platform over the past six months.

Sixty practices have completed the onboarding process to establish a link between the CancerLinQ database and their electronic health record system, and more than 1.5 million de-identified, real-world cancer patient records are now in the database. CancerLinQ is now helping these practices improve patient care through quality automation tools and dashboards and reports that provide actionable insights.


IASLC names research award after Fred R. Hirsch

The International Association for the Study of Lung Cancer has named its Translational Research Lectureship Award after longtime member and former IASLC CEO, Fred R. Hirsch. 

The award, previously named after Adi Gazdar, who died in 2018, will be called the Fred R. Hirsch Lectureship Award for Translational Research. The IASLC board also voted to name the IASLC Merit Award for Gazdar, to reflect his legacy.

The IASLC conveys lectureship awards each year at its annual World Conference on Lung Cancer to celebrate lung cancer researchers who have produced exemplary academic work and service to the IASLC, including the Translational Research Lectureship Award.

Continue reading Roswell Park signs on to participate in ASCO’s CancerLinQ

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.